Myostatin inhibition with orally administered <i>Lactobacillus casei</i> expressing a modified human myostatin protein: functional benefits and translational potential in advanced Duchenne muscular dystrophy.

Front Neurol · 2025 · PMC12836393 · PMID 41607848

Europe PMC DOI

hedged sentences

0.2900

closest p · 5.8× alpha

0.4500

boldest claim

The sentences

a decreasing trendp = 0.29not close (p > 0.1)

a slightly increasing trendp = 0.74not close (p > 0.1)

The control group showed a decreasing trend in body weight between weeks 8 and 12 ( p = 0.29), whereas the treatment group showed a slightly increasing trend over the same period ( p = 0.74; Figure 3D ).

also in 47,180 other papers

showed a trendp = 0.45not close (p > 0.1)

At 5 rpm, the treatment group showed a trend toward improvement at week 8 ( p = 0.45) and a statistically significant enhancement at week 12 ( p < 0.001).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.